Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
Recruiting · NCT06435585 · Observational (researchers observe without assigning treatment) · Lead sponsor: Karolinska University Hospital
View the official record on ClinicalTrials.gov →What this trial is about
A biobank within the Swedish national heart failure quality registry SwedeHF.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Written informed consent
- Heart failure defined by symptoms and signs of heart failure as judged by the local investigator
- Registered in SwedeHF
Exclusion criteria
- Plasma donation within 1 month of enrolment or any blood donation/blood loss \>500 mL during the 3 months prior to enrolment
- Previous allogeneic bone marrow transplant (genetics)
- In the opinion of the investigator, condition/s that may either put the patient at risk on participation or influence the results or the patient's ability to participate in the study.
Where it is running
1 location listed.
- Karolinska University hospital - Stockholm, Sweden